PMID- 23588515 OWN - NLM STAT- MEDLINE DCOM- 20140310 LR - 20220330 IS - 1809-4570 (Electronic) IS - 0482-5004 (Linking) VI - 53 IP - 1 DP - 2013 Feb TI - HLA-DRB1 allele association with rheumatoid arthritis susceptibility and severity in Syria. PG - 47-56 AB - INTRODUCTION: Rheumatoid arthritis (RA) is a complex multifactorial chronic disease. The importance of human leukocyte antigen as a major genetic risk factor for RA was studied worldwide. Although it is widely distributed in different Syrian areas, studies of human leukocyte antigen (HLA) alleles' role are absent. OBJECTIVE: The aim of our study was to determine the association of HLA-DRB1 alleles with the susceptibility and severity of RA in Syria. PATIENTS AND METHODS: Eighty-six RA patients and 200 healthy controls from Syria were genotyped using polymerase chain reaction with sequence-specific primer (PCR-SSP). Anti-CCP antibodies were measured by ELISA. Rheumatoid factor (RF), C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and disease activity score 28 (DAS-28) values were obtained from patients' medical records. DAS-28 was used to assess the clinical severity of the patients. RESULTS: The HLA-DRB1*01, *04, and *10 frequencies showed a strong association with the disease susceptibility (OR = 2.29, 95% CI = 1.11-4.75, P = 0.022; OR = 3.16, 95% CI = 2.0 -4.8, P < 0.0001; OR = 2.43, 95% CI = 1.07-5.51, P = 0.029 respectively), while the frequencies of HLA-DRB1*11, and *13 were significantly lower in RA patients than in controls (OR = 0.49, 95% CI = 0.3-0.8, P = 0.004; OR = 0.32, 95% CI = 0.15-0.69, P = 0.002, respectively). The other HLA-DRB1 alleles showed no significant difference. The frequency of anti-CCP antibodies was higher in shared epitope (SE) positive patients compared with SE-negative patients (OR = 5.5, 95% CI = 2-15.1, P = 0.00054). DAS-28 of RA patients didn't show significant difference between the SE negative and the SE positive groups. CONCLUSION: Our results indicate that HLA-DRB1*01, *04, and *10 alleles are related with RA, while HLA-DRB1*11 and *13 protect against RA in the Syrian population. FAU - Mourad, Jamil AU - Mourad J AD - School of Pharmacy, University of Damascus, Syria. jamilmourad@live.com FAU - Monem, Fawza AU - Monem F LA - eng LA - por PT - Journal Article PL - Brazil TA - Rev Bras Reumatol JT - Revista brasileira de reumatologia JID - 0404256 RN - 0 (HLA-DRB1 Chains) SB - IM MH - Arthritis, Rheumatoid/*genetics MH - Case-Control Studies MH - Female MH - *Genetic Predisposition to Disease MH - HLA-DRB1 Chains/*genetics MH - Humans MH - Male MH - Middle Aged MH - *Severity of Illness Index MH - Syria EDAT- 2013/04/17 06:00 MHDA- 2014/03/13 06:00 CRDT- 2013/04/17 06:00 PHST- 2011/12/08 00:00 [received] PHST- 2012/12/13 00:00 [accepted] PHST- 2013/04/17 06:00 [entrez] PHST- 2013/04/17 06:00 [pubmed] PHST- 2014/03/13 06:00 [medline] AID - S0482-5004(13)70057-3 [pii] PST - ppublish SO - Rev Bras Reumatol. 2013 Feb;53(1):47-56.